Stay updated on Pembrolizumab in Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Advanced Solid Tumors Clinical Trial page.

Latest updates to the Pembrolizumab in Advanced Solid Tumors Clinical Trial page
- Check2 days agoChange DetectedRevision: v3.3.3 appears in the page footer, and the HHS Vulnerability Disclosure link along with the Revision: v3.3.2 entry were removed from the footer. These changes affect only footer/policy elements and do not modify trial data or core page functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check31 days agoChange DetectedFooter revision updated from v3.2.0 to v3.3.2, indicating a minor site version update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check38 days agoChange DetectedThe page removes the generic government funding/operating-status notice.SummaryDifference0.3%

- Check52 days agoChange DetectedVersion history shows multiple updates to core trial details (recruitment status, study status, and site/ contact information) across several versions. These changes reflect updates to current trial progress and site information.SummaryDifference0.0%

- Check81 days agoChange DetectedCore content updated with a government funding notice and a new version number (v3.2.0) replacing the old one (v3.1.0); reflects status and version changes rather than substantive feature additions.SummaryDifference7%

- Check88 days agoChange DetectedMajor version update to v3.1.0 with a new study status entry and date; older revision v3.0.2 and its date removed.SummaryDifference0.9%

Stay in the know with updates to Pembrolizumab in Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Advanced Solid Tumors Clinical Trial page.